Copy Link Print Information

Vanucizumab

(Synonyms: Anti-Human VEGFA Recombinant Antibody; RO5520985)
Revisión del cliente

Based on 1 Customer Validation

Vanucizumab is a first-in-class, bispecific IgG1-like monoclonal antibody that simultaneously blocks VEGF-A and angiopoietin-2 (Ang-2) from interacting with their receptors. Vanucizumab has antiangiogenic and anticancer effects.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: 95.12%
  • No. CAS: 1448221-05-3
  • Peso molecular:146.89 kDa
  • Almacenamiento:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Vanucizumab
  • Experimental Validation Results for Vanucizumab
  • Experimental Validation Results for Vanucizumab
  • Experimental Validation Results for Vanucizumab
  • Vanucizumab Chemical Structure
    Vanucizumab Chemical Structure
No. CAS: 1448221-05-3
Tamaño
Precio
Stock
Cantidad
Amount: USD 0.00
Please select quantity
or
or

* Seleccione Cantidad antes de agregar artículos.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Vanucizumab Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Encuentre su distribuidor local Your local distributor: Hycultec GmbHHycultec
  • Actividad biológica
  • Chemical Information
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Ver todos los productos específicos de isoformas VEGFR

More

Ver todos los productos específicos de isoformas Tie

More
Keywords
100 mg

Obtener un presupuesto En stock

Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Inicie sesiòn
Registrar
Sign in to MedChemExpress
Registrar una cuenta nueva

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    IgG1-kappa-lambda with half-IG VL-CH1/VH-CK crossover

  • 1/16

    Immobilized Human VEGFA, His Tag can bind Vanucizumab. The EC50 for this effect is 4.575 ng/mL.

  • 1/16

    Immobilized Human ANGPT2, His Tag can bind Vanucizumab. The EC50 for this effect is 78.70 ng/mL.

  • 1/16

    Flow cytometric analysis of 1X106 HeLa cells with Vanucizumab (HY-P99330, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. AF488-conjugated AffiniPure Goat Anti-Human IgG H&L (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control.

  • Vanucizumab Chemical Structure
    1/16
  • Vanucizumab
  • Immobilized Human VEGFA, His Tag can bind Vanucizumab. The EC50 for this effect is 4.575 ng/mL.
  • Immobilized Human ANGPT2, His Tag can bind Vanucizumab. The EC50 for this effect is 78.70 ng/mL.
  • Flow cytometric analysis of 1X106 HeLa cells with Vanucizumab (HY-P99330, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. AF488-conjugated AffiniPure Goat Anti-Human IgG H&L (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control.
  • IgG1-kappa-lambda with half-IG VL-CH1/VH-CK crossover